- Home
- OPRX vs OABI Comparison
OPRX vs OABI Comparison
Compare OPRX & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPRX
- OABI
- Stock Information
- Founded
- OPRX 2006
- OABI 2012
- Country
- OPRX United States
- OABI United States
- Employees
- OPRX N/A
- OABI N/A
- Industry
- OPRX Business Services
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- OPRX Consumer Discretionary
- OABI Health Care
- Exchange
- OPRX Nasdaq
- OABI Nasdaq
- Market Cap
- OPRX 234.9M
- OABI 250.8M
- IPO Year
- OPRX N/A
- OABI N/A
- Fundamental
- Price
- OPRX $12.50
- OABI $1.91
- Analyst Decision
- OPRX Buy
- OABI Strong Buy
- Analyst Count
- OPRX 8
- OABI 3
- Target Price
- OPRX $10.81
- OABI $7.00
- AVG Volume (30 Days)
- OPRX 184.1K
- OABI 596.9K
- Earning Date
- OPRX 08-07-2025
- OABI 08-06-2025
- Dividend Yield
- OPRX N/A
- OABI N/A
- EPS Growth
- OPRX N/A
- OABI N/A
- EPS
- OPRX N/A
- OABI N/A
- Revenue
- OPRX $94,365,000.00
- OABI $26,744,000.00
- Revenue This Year
- OPRX $14.44
- OABI N/A
- Revenue Next Year
- OPRX $10.63
- OABI $45.02
- P/E Ratio
- OPRX N/A
- OABI N/A
- Revenue Growth
- OPRX 20.66
- OABI 27.07
- 52 Week Low
- OPRX $3.78
- OABI $1.22
- 52 Week High
- OPRX $15.71
- OABI $4.87
- Technical
- Relative Strength Index (RSI)
- OPRX 43.16
- OABI 48.46
- Support Level
- OPRX $12.51
- OABI $1.90
- Resistance Level
- OPRX $13.41
- OABI $2.19
- Average True Range (ATR)
- OPRX 0.94
- OABI 0.10
- MACD
- OPRX -0.14
- OABI -0.03
- Stochastic Oscillator
- OPRX 16.61
- OABI 21.43
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.